Statistics about Health, Pharma & Medtech in United States
Statistics
- Enanta Pharmaceuticals net cash 2019-2023
- Ngm Biopharmaceuticals Inc operating profit 2019-2023
- Allovir total assets 2019-2023
- Codiak Biosciences, Inc. operating profit 2019-2021
- Tango Therapeutics, Inc. liabilities 2020-2023
- Enanta Pharmaceuticals total equity 2019-2023
- Biocept Inc net income 2019-2022
- Omega Therapeutics liabilities 2020-2023
- Enanta Pharmaceuticals operating profit 2019-2023
- Rapid Therapeutic Science Laboratories, Inc. gross profit 2018-2022
- Biocept Inc total equity 2018-2022
- Biocept Inc net cash 2018-2022
- Enanta Pharmaceuticals net income 2019-2023
- Biocept Inc total assets 2018-2022
- Enanta Pharmaceuticals liabilities 2019-2023
- Enanta Pharmaceuticals revenue 2019-2023
- One World Products, Inc. operating profit 2019-2023
- Ovid Therapeutics operating profit 2019-2023
- Biocept Inc operating profit 2018-2022
- Biocept Inc gross profit 2013-2014
- Biocept Inc revenue 2018-2022
- Cymabay Therapeutics, Inc. net income 2019-2023
- Rapid Therapeutic Science Laboratories, Inc. total assets 2018-2022
- Meridian Bioscience Inc revenue 2018-2022
- Biogen gross profit 2016-2020
- Editas Medicine revenue 2019-2023
- Editas Medicine net cash 2019-2023
- Editas Medicine total equity 2019-2023
- Editas Medicine net income 2018-2022
- One World Products, Inc. total equity 2019-2023
- Ovid Therapeutics total equity 2019-2023
- Ontrak, Inc. total equity 2019-2023
- Outlook Therapeutics, Inc. total equity 2019-2023
- Oncotelic Therapeutics, Inc. total equity 2019-2023
- Oric Pharmaceuticals total equity 2019-2023
- Organogenesis Holdings total equity 2019-2023
- Orgenesis total equity 2019-2023
- Optinose total equity 2019-2023
- Biogen net cash 2019-2023
- Oncternal Therapeutics, Inc. total equity 2019-2023
- Editas Medicine operating profit 2019-2023
- Biogen total equity 2019-2023
- Omega Therapeutics total equity 2019-2023
- Biogen operating profit 2017-2021
- Biogen liabilities 2019-2023
- Oncorus total equity 2018-2022
- Biomarin Pharmaceutical total assets 2019-2023
- Biomarin Pharmaceutical net cash 2019-2023
- Biomarin Pharmaceutical total equity 2019-2023
- Olema Pharmaceuticals total equity 2019-2023
- Elicio Therapeutics, Inc. net cash 2020-2023
- Biomarin Pharmaceutical liabilities 2019-2023
- Elicio Therapeutics, Inc. total assets 2020-2023
- Biomarin Pharmaceutical revenue 2019-2023
- Biomarin Pharmaceutical operating profit 2019-2023
- Palisade Bio, Inc. revenue 2018-2023
- Editas Medicine liabilities 2019-2023
- Elicio Therapeutics, Inc. liabilities 2020-2023
- Oyster Point Pharma, Inc. net cash 2018-2021
- Meridian Bioscience Inc net cash 2018-2022
- Meridian Bioscience Inc operating profit 2018-2022
- Meridian Bioscience Inc total assets 2018-2022
- Altimmune revenue 2019-2023
- Meridian Bioscience Inc total equity 2018-2022
- Meridian Bioscience Inc net income 2018-2022
- Third Harmonic Bio liabilities 2021-2023
- Altimmune liabilities 2019-2023
- Altimmune total assets 2019-2023
- Eledon Pharmaceuticals operating profit 2019-2023
- Palisade Bio, Inc. net cash 2019-2023
- Thorne Healthtech liabilities 2020-2022
- Coeptis Therapeutics Holdings total assets 2019-2023
- Coeptis Therapeutics Holdings total equity 2019-2023
- Pacific Health Care liabilities 2019-2023
- Theseus Pharmaceuticals, Inc. liabilities 2020-2022
- Palisade Bio, Inc. liabilities 2019-2023
- Elevation Oncology net income 2020-2023
- Elevation Oncology total equity 2019-2023
- Oyster Point Pharma, Inc. liabilities 2018-2021
- Elevation Oncology total assets 2020-2023
- Elevation Oncology liabilities 2020-2023
- Pacific Health Care operating profit 2019-2023
- Elevation Oncology operating profit 2020-2023
- Elevation Oncology net cash 2020-2023
- Palisade Bio, Inc. operating profit 2019-2023
- Oyster Point Pharma, Inc. operating profit 2018-2021
- Altimmune total equity 2019-2023
- Pacific Health Care revenue 2019-2023
- Editas Medicine total assets 2019-2023
- Elicio Therapeutics, Inc. total equity 2019-2023
- One World Products, Inc. total assets 2019-2023
- Disc Medicine, Inc. net income 2020-2023
- Biomerica revenue 2019-2023
- Rubius Therapeutics total equity 2018-2022
- Omega Therapeutics total assets 2020-2023
- Olema Pharmaceuticals total assets 2020-2023
- Nutra Pharma Corp gross profit 2017-2021
- Oncternal Therapeutics, Inc. total assets 2019-2023
- Eli Lilly net cash 2019-2023
- Biomerica total equity 2020-2024